Bio-Rad Laboratories BIO
NYSE BIO
$376.85 -3.27 (-0.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) FCF Margin Growth (3y) (2012 - 2026)

Analysis

Bio-Rad Laboratories (BIO) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Thermo Fisher Scientific 225.48 Bn 221.41 Bn 8.34 Bn 221.00
2 Danaher 144.42 Bn 140.08 Bn 3.61 Bn -682.00
3 Agilent Technologies 40.86 Bn 39.11 Bn 1.04 Bn -539.00
4 Illumina 30.97 Bn 29.80 Bn 770.00 Mn 896.00
5 Revvity 13.85 Bn 12.83 Bn 416.87 Mn 4,700.00
6 Bio-Techne 11.27 Bn 11.01 Bn 211.39 Mn 299.00
7 Bio-Rad Laboratories 10.11 Bn 8.49 Bn 345.80 Mn 93.00
8 Repligen 9.33 Bn 8.31 Bn 110.04 Mn -304.00
9 10x Genomics 8.77 Bn 8.21 Bn 112.50 Mn 1,752.00
10 Bruker 8.30 Bn 8.09 Bn 416.00 Mn -1,113.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.00
Mar 31, 2026 397.00
Dec 31, 2025 1,105.00
Sep 30, 2025 1,609.00
Jun 30, 2025 566.00
Mar 31, 2025 1,383.00
Dec 31, 2024 -347.00
Sep 30, 2024 -721.00
Jun 30, 2024 -967.00
Mar 31, 2024 -810.00
Dec 31, 2023 -2,540.00
Sep 30, 2023 -939.00
Jun 30, 2023 -447.00
Mar 31, 2023 201.00
Dec 31, 2022 -1,600.00
Sep 30, 2022 -1,468.00
Jun 30, 2022 -1,806.00
Mar 31, 2022 -100.00
Dec 31, 2021 737.00
Sep 30, 2021 1,882.00